Michael Randolph
Corporate Officer/Principal presso ENDO INTERNATIONAL PLC
Profilo
Michael Randolph is currently the Global Head-Manufacturing Operations at Endo International Plc.
He has a graduate degree from Georgia Institute of Technology and an undergraduate degree from North Carolina State University.
Posizioni attive di Michael Randolph
Società | Posizione | Inizio |
---|---|---|
ENDO INTERNATIONAL PLC | Corporate Officer/Principal | 01/06/2022 |
Formazione di Michael Randolph
Georgia Institute of Technology | Graduate Degree |
North Carolina State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Michael Randolph